Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
43.58
+0.83 (1.94%)
At close: Jun 27, 2025, 4:00 PM
41.41
-2.17 (-4.98%)
After-hours: Jun 27, 2025, 7:41 PM EDT
Claritev Market Cap
Claritev has a market cap or net worth of $716.30 million as of June 27, 2025. Its market cap has increased by 120.04% in one year.
Market Cap
716.30M
Enterprise Value
5.33B
1-Year Change
120.04%
Ranking
Category
Stock Price
$43.58
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $716.30M, an increase of 194.77%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 663.21M | 177.48% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |